Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
09/2010
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010106269A2 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010CA2755526A1 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/22/2010EP2076506B1 Heterocyclic-substituted piperidines as orl-1 ligands
09/22/2010CN101838266A Citric acid tropisetron raw material medicine and preparation technology of raw material medicine and injection liquid
09/21/2010CA2451573C Technical process for the manufacture of tropenol
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2405002C Antitumoral analogs of et-743
09/16/2010WO2010048526A3 Modulators of cystic fibrosis transmembrane conductance regulator
09/16/2010US20100234395 Ureide derivative and pharmaceutical application thereof
09/16/2010US20100234392 4-sulfonylpiperidine derivatives
09/16/2010US20100234354 Pyridazinone derivatives
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/10/2010WO2010101538A2 New crystal forms
09/09/2010US20100227883 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/08/2010CN101824033A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/02/2010US20100221181 Method of differentially diagnosing different types of dementia
09/01/2010EP1874766B1 Crystalline form of a quinolinone-carboxamide compound
09/01/2010CN101821265A Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11ss-hydroxysteroid dehydrogenase type-1
09/01/2010CN101817815A Compounds with antibacterial activity
08/2010
08/26/2010US20100217002 Novel chromen-2-one derivatives
08/26/2010US20100216988 Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216726 Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof
08/25/2010EP2221306A1 Method for producing 2-azaadamantane
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/18/2010EP2217596A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/18/2010EP1682543B1 Methods for the production of novel tiotropium salts
08/17/2010US7776888 such as 3-[2-(2-methoxy-ethoxymethyl)-6-trifluoromethyl-pyridine-3-carbonyl]-1,5-dimethyl-8-oxa-bicyclo[3.2.1]oct-6-ene-2,4-dione, used for controlling undesired plant growth or weeds
08/17/2010US7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
08/12/2010US20100204264 Polymorphic form of granisetron base, methods for obtaining it and formulation containing it
08/11/2010CN101801378A Novel combination of therapeutic agents
08/11/2010CN101798257A Automatic synthesis method of methylation reagent [11C] CH3Br
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/05/2010WO2010086612A1 Process for preparing enantiomerically enriched alkaloids
08/05/2010US20100197922 Azabicycloalkane compounds
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010CA2751285A1 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
08/04/2010EP2212320A1 Chemical synthesis of i-124beta cit iodine-124 [2-beta-carbomethoxy-3beta- (4. -iodophenyl) -tropane] for pet investigations and for radiotherapy
08/04/2010EP2212319A1 Labeled iodinated tropane formulation
08/03/2010US7767814 2-benzyl-3-[4a-(3-hydroxy-phenyl)-10a-methyl-3,4,4a,5,10,10a-hexahydro-1H-benzo[g]isoquinolin-2-yl]-propionic acid, used for prevention or treatment of gastrointestinal disorders, obesity, pain and reducing side effects associated with an opioid such as constipation, nausea and vomiting
07/2010
07/29/2010WO2010085684A1 Compositions and methods for inhibition of the jak pathway
07/29/2010US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity
07/29/2010US20100190821 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors
07/29/2010CA2749217A1 Compositions and methods for inhibition of the jak pathway
07/28/2010CN101790529A 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
07/28/2010CN101787021A High-purified tropisetron hydrochloride compound
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763637 Gastrointestinal disorders; selectivity, potency, pharmacokinetics, duration of action; minimal side effects
07/27/2010CA2373559C Serotonin transport inhibitors
07/22/2010US20100184987 Preparation of Retapamulin via its Pleuromutilin-thiol precursor
07/21/2010EP1610789B1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
07/15/2010WO2010080474A1 Carbazole and carboline kinase inhibitors
07/15/2010US20100179164 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
07/14/2010EP2206712A1 "Alkaloid aminoester derivatives and medicinal composition thereof"
07/14/2010EP2205597A1 Method for producing (1r,5s) anhydroecgonine ester salts
07/13/2010US7754886 N-acylsulfonamide apoptosis promoters
07/08/2010US20100173935 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia
07/07/2010EP2204368A1 4-sulfonylpiperidine derivatives
07/07/2010CN101768158A Tiotropium bromide anhydride and preparation method thereof
07/01/2010WO2010075273A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010WO2010074387A1 Aza-bicyclo[2.2.1] heptene derivatives, preparation method thereof, and method for preparing oseltamivir intermediates using the same
07/01/2010WO2010072338A1 Alkaloid aminoester derivatives and medicinal composition thereof
07/01/2010WO2010046445A3 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
07/01/2010US20100168083 Adamantane derivatives for the treatment of the metabolic syndrome
07/01/2010CA2748100A1 Alkaloid aminoester derivatives and medicinal composition thereof
06/2010
06/30/2010CN101765599A Tropane derivatives useful as pesticides
06/30/2010CN101759696A Improvement of nortropine synthesizing process
06/29/2010US7745628 Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/17/2010WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152148 Novel compounds
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/16/2010EP2195315A1 Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
06/16/2010EP2195314A1 Disubstituted alkyl-8-azabicyclo [3.2.1.]octane compounds as mu opioid receptor antagonists
06/16/2010EP2195313A1 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/16/2010CN101743245A Process for preparing an intermediate to mu opioid receptor antagonists
06/16/2010CN101099286B Method and installation means for installing an electrical machine
06/15/2010CA2383340C Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
06/10/2010WO2010031517A8 Radioactively marked cyclopropane derivatives of dat affine tropanes
06/09/2010EP2194053A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
06/09/2010CN1982309B Industrial synthesis method for producing tropenol
06/09/2010CN1880319B Tropane derivatives as CCR5 modulators
06/09/2010CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732441 Azabicycloalkane compounds
06/03/2010WO2010028213A3 N-sulfonamido polycyclic pyrazolyl compounds
06/03/2010WO2010014257A3 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
06/02/2010EP2190831A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
06/02/2010EP2190824A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 53